Oncogenic potential of Nrf2 and its principal target protein heme oxygenase-1

Hye-Kyung Na1, Young-Joon Surh2

  • 1Department of Food & Nutrition, College of Human Ecology, Sungshin Women's University, Seoul 142-732, South Korea.

Insights

Nuclear factor erythroid 2-related factor 2 (Nrf2) and heme oxygenase-1 (HO-1) are crucial for cellular defense but are paradoxically hijacked by cancer. Elevated Nrf2 and HO-1 promote tumor growth, metastasis, and treatment resistance.

Area of Science:

  • Molecular Biology
  • Cellular Biology
  • Oncology

Background:

  • Nuclear factor erythroid 2-related factor 2 (Nrf2) is a key regulator of cellular defense against oxidative stress and various insults.
  • Nrf2 orchestrates the expression of cytoprotective proteins, notably heme oxygenase-1 (HO-1).
  • Recent evidence reveals oncogenic roles for both Nrf2 and HO-1 in cancer progression.

Purpose of the Study:

  • To review the dual role of the Nrf2-HO-1 axis in cancer.
  • To highlight how cancer cells exploit this pathway for growth and survival.
  • To discuss Nrf2 and HO-1 as potential therapeutic targets in oncology.

Main Methods:

  • Literature review of recent studies on Nrf2 and HO-1 in cancer.
  • Analysis of the role of Nrf2-HO-1 in tumor microenvironment modulation.
  • Examination of Nrf2-HO-1 involvement in cancer cell proliferation, metastasis, and treatment resistance.

Main Results:

  • Elevated Nrf2 and HO-1 levels are observed in numerous human malignancies.
  • The Nrf2-HO-1 pathway promotes cancer cell proliferation, angiogenesis, and metastasis.
  • This axis confers resistance to chemotherapy, radiotherapy, and photodynamic therapy.

Conclusions:

  • The cellular stress response mediated by Nrf2-HO-1 is co-opted by cancer cells for survival and proliferation.
  • Targeting the Nrf2-HO-1 pathway presents a promising therapeutic strategy for cancer management.
  • Further research into inhibiting Nrf2 and HO-1 could lead to novel cancer treatments.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.7K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.2K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

6.1K
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

2.0K
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
6.7K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K